All posts by imreal

Light Side Floats backs documentary bringing global awareness to the benefits of Floatation Therapy for anxiety and pain relief


News Image

Light Side Floats, the premiere floatation therapy center in Frederick, Maryland backed the FLOATING documentary, with the goal of spreading global awareness about Floatation-REST, an effective therapy for anxiety, PTSD, pain relief and eating disorders without the use of drugs. The long-awaited documentary made its worldwide debut on October 9th, 2022. Light Side Floats owners Tom and Alyssa Palermo received casting credits for their roles in the film.

In the FLOATING documentary Shane Stott, author of The Float Tank Cure, introduces floating to people in different parts of the United States who are suffering from chronic pain, PTSD, and anxiety. We follow their journey of floating and witness how they learn to heal themselves. “Floatation-REST is the most advanced tool our society has to help calm a stressed and anxious nervous system.” – Dr. Justin Feinstein, Ph.D. Clinical Neuropsychologist

FLOATING is a GoldenStott film, directed by Bridger Dopp.

https://youtu.be/mRaJAzZ2LoM

Light Side Floats is a business born out of pain. Co-founder Tom Palermo began floating in 2015 to ease his chronic back pain and PTSD. After his first float, he was able to sleep through the night which is something he hadn’t done for years. Soon after his wife Alyssa began floating to help reduce stress. The closest float center was more than 30 miles away from their home. Wanting to help people in their community feel better naturally, the couple opened Light Side Floats in 2016. In addition to Floatation Therapy, the business also offers hydro massage and infrared sauna.

Share article on social media or email:

Improved Pharma presenting at AAPS 2022 PHARMSCI 360 with Rapid Fire Presentation and Posters


News Image

Improved Pharma is presenting their research on all three days of the AAPS conference. On Monday October 17th at 2:30 pm, please visit monitor #31 in forum 6. Ms. Ruba Alajlouni will present “Feasibility of Synchrotron XRD for the analysis of mixture sub-samples.” She will share results demonstrating the effective utilization of synchrotron XRD (SXRD) for the analysis of mixtures.

On Tuesday, Improved Pharma has two posters presented concurrently at 2:30 pm in forum 8 (monitor numbers 45 and 46). Dr. Susan-Bogdanowich-Knipp, President of Ravine Pharmaceuticals and Consultant with Improved Pharma, will present “Green Chemistry Initiative for Formulating, Pressing and Evaluating Tablets in Low-Resource Settings.” She will describe how ingredients found in an African grocery store were used to make wet granulations and hand-pressed into tablets that were assessed via friability and disintegration times.

Dr. Pamela Smith, COO of Improved Pharma, will present “Using Raman Mapping to Detect and Identify Challenging Degradation Products and Complex Drug-Drug Interactions in a Tablet.” Raman mapping results collected on an expired tablet will be presented. Peak height ratio profiles and spectral subtractions were used to locate and identify degradation products in very low amounts that would not be detectable if a bulk Raman technique was used.

On Wednesday, please attend our Rapid Fire presentation at 3:15 in 205 C. Mr. Stephan Parent will present “Pharmaceutical Experiments for Microgravity.” The presentation will provide a brief overview of the advantages of executing pharmaceutical experiments in microgravity over corresponding land-based methods. Featured will be research into melt/quench hardware that resulted in the discovery of form III of ritonavir. Improved Pharma is also designing and testing hardware that will provide antisolvent crystallization and evaporation capabilities in microgravity. This presentation will focus on the solid-state chemistry whereas Varda Space Industries will present efforts focused on the hardware. Varda’s presentation “Development of Reentry Vehicles and Payloads for In-Orbit drug Development” is on Tuesday at 3:15 in form 205 AB.

About Improved Pharma

Improved Pharma is a research, consulting, and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.

For more information about the topics discussed in this press release or about Improved Pharma’s services, please contact us at 1-765-463-9951 or info@improvedpharma.com.

Share article on social media or email:

MedVet Offers Scholarships and Career Opportunities for Aspiring ER Veterinarians


This is an opportunity for veterinary students to receive substantial financial support to wrap up veterinary school while also jump-starting a fulfilling career in emergency medicine after graduation with the team that is Leading Specialty Healthcare for Pets.

MedVet has opportunities for aspiring emergency medicine veterinarians in the class of 2023 to receive a scholarship, signing bonus, and guaranteed position in MedVet’s profession-leading Emergency Clinician Mentorship Program (ECMP) after graduation.

Candidates who sign at an eligible location by Dec. 31, 2022, will receive a $15,000 scholarship for their last semester of veterinary school (amount not to exceed the total for tuition and fees). They’ll also receive a signing bonus of up to $35,000 which varies by location. Eligible hospital locations include Akron (OH), Asheville (NC), Cincinnati (OH), Chicago (IL), Diley Hill (OH), Indianapolis (IN), Lexington (KY), Mobile (AL), Norwalk (CT), Pittsburgh (PA), and Toledo (OH).

“This is an opportunity for veterinary students to receive substantial financial support to wrap up veterinary school while also jump-starting a fulfilling career in emergency medicine after graduation with the team that is Leading Specialty Healthcare for Pets,” said Dr. Jon Fletcher, Director of Post-Graduate Medical Education at MedVet.

Following graduation, accepted candidates will join MedVet as ECMP doctors. The ECMP is an accelerated training program that allows new veterinarians to enhance their diagnostic and therapeutic capabilities, advance clinical decision-making and technical skills, and hone their communication. At the center of the program is a mentor-mentee relationship that ensures a smooth transition into emergency medicine.

“The ECMP is the premier training program for developing ER veterinarians. They are entrusted with all the duties of an emergency veterinarian, but with their mentor by their side, they are never left alone or lost in the shuffle. This program is tailor-made to fit the unique needs and goals of the mentee and, as a result, they show unbelievable clinical growth,” explained Dr. Mackenzie Ruehl, Medical Director at MedVet Hilliard and ECMP Training Director.

To apply, veterinary students in their final year of veterinary school should contact Amanda Purcell at Amanda.purcell@medvet.com or 614.368.2568. Candidates can also learn more about MedVet and the ECMP on medvet.com.

About MedVet:

MedVet is the leading veterinarian owned and led family of specialty and emergency hospitals dedicated to delivering exceptional care and a deeply supportive experience to pets and their loving families, referring veterinarians, and team members. For more than 30 years, MedVet’s empathetic, insightful, and driven team of expert caregivers has helped the organization grow to be the preferred choice for high quality, compassionate care, proudly serving more than 500,000 patients each year in communities throughout the United States. To learn more about MedVet and its mission of Leading Specialty Healthcare for Pets, visit medvet.com. 

###

Share article on social media or email:

Activate Care and Kronos Health Partner to Address Social Determinants of Health


Activate Care®, a leader in social risk management solutions, today announced a partnership with Kronos Health. The primary healthcare provider based in Lawrence, MA has begun offering Activate Care’s Path Assist, a proactive model that addresses a person’s SDOH-driven needs and navigates them through an intervention with a Community Health Navigator to improve patient outcomes and lower costs of care.

By driving action upstream, Path Assist takes a whole-person approach to care interventions – a departure from the traditional model that retroactively responds to healthcare events, such as a visit to the emergency room triggered by a lack of shelter.

“I believe we need to redesign primary health care delivery to better serve the needs of all patients,” said Dr. Scott Early, founder of Kronos Health. “By deploying Activate Care’s Path Assist, we are taking a proactive approach to the factors that impact a person’s health, such as housing, food security and transportation, in order to better address the whole patient and drive better health outcomes and improve people’s quality of life.”

How it Works

Path Assist is available to all patients within Kronos Health’s community. Once enrolled, patients are assigned a Community Health Navigator (CHN) who listens to their needs, helps create goals, connects them to local resources and services and coaches them to improve health confidence.

To take advantage of the program, people need to follow four easy steps:

● Sign up online or ask their provider

● Complete a screening to help understand each individual’s needs

● Connect with a CHN virtually or physically each week

● Receive up to three months of services

“For too long, we have taken a very narrow view of healthcare – that it’s what happens when a person is in the office,” said Activate Care’s CEO and Co-Founder, Ted Quinn. “But that is not always helping people how, when and where they need it. As more healthcare providers integrate SDOH into their care delivery models, we will begin to see real change in patients’ health outcomes, satisfaction and trust in the healthcare system – and the amount we’re collectively spending on healthcare. Taking a whole-person approach to care, like Kronos Health, is a win for everyone.”

To connect with Activate Care to learn how Path Assist can address SDOH in your community, visit: https://path-assist.com/client-howitworks/.

About Activate Care®

At Activate Care, we’re on a mission to improve health equity and drive improved health outcomes across the country. We do this by providing direct support to individuals navigating social health challenges. Our locally-hired workforce is trained to engage and empower individuals using best practices while leveraging secure, accessible technology. Our goal is simple: improve poor outcomes and reduce high cost due to Social Determinants of Health. We are confident of the potential of our solution, Path Assist, to positively impact the health of communities with an effective, efficient, and measurable model which is locally responsive and nationally scalable.

For more information, visit https://www.activatecare.com.

About Kronos Health

Kronos Health is an innovative primary care practice serving the Merrimack Valley in Massachusetts. The aim of Kronos Health is to provide better care to patients by building a comprehensive and proactive model of care. Kronos Health fundamentally re-designs how health care is delivered, especially in underserved communities. Kronos Health believes that providing sufficient time to do a good job will improve the quality of care, decrease waste and improve the satisfaction of patients and the professionals who care for them.

For more information, visit https://www.kronoshealth.com/.

Share article on social media or email:

Verinovum Partners with Former NCQA Executives


“Michael and Rick will help lead our charge to unleash the full potential of healthcare data.” — Mike Noshay, co-founder and Chief Strategy and Marketing Officer.

Verinovum – a health data curation and enrichment technology company – announces strategic partnerships with Michael Barr, MD, and Rick Moore, PhD, two healthcare leaders and former executives at the National Committee for Quality Assurance (NCQA).

The addition of these healthcare luminaries enhances Verinovum’s goal to help payers, providers, and vendors enhance the care experience, improve population health, promote health equity, and reduce costs. The duo will also play key roles in providing product and data governance counsel as Verinovum takes the next step in its growth.

“High-quality clinical data is mission critical for organizations to effectively impact the health of their populations and implement constructive operational changes. Michael and Rick will help lead our charge to unleash the full potential of healthcare data,” says Mike Noshay, co-founder and Chief Strategy and Marketing Officer at Verinovum. “Our healthcare data curation expertise combined with their NCQA leadership improving the experience and quality of healthcare is a winning combination.”

For more than 30 years, Dr. Barr has delivered programs, policies, and services aimed at equitable, accessible, evidence-based, and person-centered care. As Executive Vice President of Quality Measurement and Research at the NCQA, Barr oversaw performance measurement development, research and analysis, management of contracts and grants, and NCQA’s consulting activities. He also led the digital measures strategy for HEDIS® and contributed to public policy, educational programs, and other initiatives.

Moore is an award-winning, board-certified, healthcare strategist with more than 25 years of experience in the federal government and non-profit sectors. His focus is on uniting teams to drive efficient data collection and management through the design, implementation, and operation of informatics infrastructures.

As NCQA’s Chief Information Officer, he was responsible for the vision and strategic direction of the Information Services, Information Technology, and Information Products. In addition, he is an expert in privacy/security-based compliance with federal mandates, including HIPAA and HITRUST, and led the only program in the country to receive Office of the National Coordinator for Health Information Technology approval as a quality measurement test system.

About Verinovum

Verinovum provides data curation and enrichment solutions that help organizations improve operating performance. Verinovum delivers clean, complete, and accurate data, supporting healthcare organizations in accessing the right information, in the right format, at the right time, to fulfill specific use cases and achieve clinical and business goals. Discover more at Verinovum.com.

Share article on social media or email:

U.S. Drug Distribution Industry Expands as COVID-19 Disruption Fades and Biosimilars Boom


The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The Inflation Reduction Act of 2022 will trigger multiple changes in pharmacy and provider markets that will negatively impact wholesalers, although wholesalers may indirectly benefit from certain aspects of the legislation.

Today Drug Channels Institute (DCI) released its exclusive analysis of U.S. prescription drug distribution channels. DCI’s new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors delves into the business operations and industry environment of the Big Three public drug wholesalers—AmerisourceBergen, Cardinal Health, and McKesson.

“U.S. drug distribution revenues at the largest wholesalers have accelerated, as pharmacy and provider markets have recovered from the disruptions of the COVID-19 pandemic,” says Drug Channels Institute CEO Adam J. Fein, Ph.D., the study’s author and a widely regarded expert on pharmaceutical economics and the drug distribution system. “Wholesalers now generate significant profits from provider-administered biosimilar drugs. We project that overall U.S. drug distribution revenues at the Big Three wholesalers will reach $616 billion in 2022.”

Now in its 13th edition, The 2022-23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors offers 150 proprietary charts, exhibits, and data tables. It remains the most comprehensive resource for analyzing the pharmaceutical distribution industry’s economics, market structure, growth rates, forces of change, and interactions within the U.S. healthcare system. The new report also provides an updated analysis of each of the Big Three public companies’ business segments and underlying profitability, based upon DCI’s proprietary economic models.

The 2022-23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors analyzes the crucial healthcare trends affecting pharmaceutical wholesalers, including: the outlook for brand-name drug prices; the evolution of the pharmacy industry; changes to buy-and-bill channels; vertical integration by hospitals; cell and gene therapies; importation; and much more.

Fein adds, “The Inflation Reduction Act of 2022 will trigger multiple changes in pharmacy and provider markets that will negatively impact wholesalers, although wholesalers may indirectly benefit from certain aspects of the legislation.”

To purchase and immediately download the new report, visit https://drugch.nl/wholesale. To read a free report overview, visit https://drugch.nl/overview-2022-23

About Drug Channels Institute

Drug Channels Institute is a leading source of industry research about pharmaceutical economics and the drug distribution system. To learn more about its products, visit http://www.drugchannelsinstitute.com. Access Dr. Fein’s popular Drug Channels blog at http://www.drugchannels.net.

Media Contact:

Tamra Feldman

Drug Channels Institute

215-523-5700

Email: admin@drugchannels.net

Share article on social media or email:

Award-Winning Fertility Doctor Joins Reproductive Specialists of the Carolinas


Reproductive Specialists of the Carolinas (“RSC”) is pleased to announce that Dr. Luwam Ghidei, an award-winning reproductive endocrinologist and infertility specialist, has joined the boutique fertility practice, making it possible for even more patients to receive advanced and inclusive reproductive care.

Dr. Ghidei has the training and experience to diagnose and treat all infertility causes, with a specific interest in recurrent pregnancy loss, infertility, fibroids, polycystic ovarian syndrome, fertility preservation, third-party reproduction, and resolving healthcare disparities. She received her medical degree from the University of Texas Southwestern Medical School before completing an Obstetrics and Gynecology residency at Brown University/Women and Infants Hospital in Providence, Rhode Island. She completed her fellowship in Reproductive Endocrinology and Infertility, as well as a Master of Science in clinical investigation at Baylor College of Medicine.

In addition to her impressive background and training, Dr. Ghidei has also won numerous awards, including most recently the President’s Presenter Award from the Society for Reproductive Investigation, and has published many studies in peer-reviewed journals to further advance reproductive medicine and optimize patient experiences.

As a passionate supporter of equal rights for everyone, Dr. Ghidei is committed to honoring the pillars of inclusivity and advocacy that define the RSC practice. “It is my goal and privilege to provide each of my patients with compassionate and respectful care, while helping them achieve their individualized reproductive goals,” she says.

Dr. Johnson said: “I am so grateful to have a new, young, intelligent, and passionate REI join our team at RSC! With Dr. Ghidei’ s passion and modern outlook on fertility care, I know that our patients and staff alike will undoubtedly benefit with her addition to the team. Welcome to RSC, Dr. Ghidei!”

The addition of Dr. Ghidei to the staff comes on the heels of a practice relocation earlier this year. The new 11,000-square-foot facility in Charlotte, NC includes a state-of-the-art IVF laboratory, and further enhances treatment offerings for patients, which include intrauterine insemination (IUI), infertility assessments, oncofertility, in vitro fertilization (IVF), egg freezing, and more.

Reproductive Specialists of the Carolinas is located at 1918 Randolph Rd, Ste 410, Charlotte, NC 28207-1109. To learn more, please email info@fertilitycarolinas.com or call to schedule an appointment to see Dr. Ghidei at (704) 247-2209.

Share article on social media or email:

atria health Partners with Leading Independent Physician Group in Greater Philadelphia Area


atria health announced today that it has entered into a long-term partnership with leading independent physician practice AMS Cardiology (AMS) in Montgomery County, PA. This first-of-its-kind partnership expands upon atria’s efforts to empower community cardiologists to transform how care is delivered and paid for nationally.

“We are excited about the opportunity to partner with atria to improve access to comprehensive, integrated care for our patients,” said Adam Cohen, MD, Managing Partner of AMS Cardiology. “atria’s unique operating model allows our practice to remain truly independent while supporting us with the resources necessary to accelerate growth and clinical innovation in our market.”

“Legacy models for treating and paying for cardiac care have failed to innovate and put patients first,” said Scott Shapiro, MD, AMS cardiologist and Chief Strategy Officer at The Physicians Integrated Network (TPIN). “Partnering with atria reinforces our patient-centric and physician-driven philosophy and delivers the resources and expertise necessary to serve the individual needs of our patients through a sustainable, quality-focused approach.”

The company also announced the appointment of experienced industry executive Matt Eakins, MD to its Board of Directors.

Dr. Eakins serves as the Chief Innovation Officer of Unified Women’s Healthcare, a diversified women’s health company supporting over 2,500 providers across more than 900 locations. He leads the Diversified Business Group, which was created to find and grow strategic partnerships with payor organizations and other community-based healthcare providers seeking to improve quality and health outcomes for patients. Previously, Dr. Eakins was Chief Operating Officer for Unified and Senior Vice President of Operations. Prior to joining Unified, Dr. Eakins was a management consultant at McKinsey & Company, advising clients across the healthcare value chain.

“We are delighted to welcome Matt to our Board as an independent director,” said Dr. Cohen. “He has been instrumental in the formation of atria and brings a wealth of experience in healthcare innovation, most notably in building high performing provider organizations and pioneering the implementation of alternative payment models.”

About atria health

atria health is a physician-owned practice support organization. The company enables a network of high-performing, community-based heart specialists to redefine the role of the physician in cardiac care. For more information, please visit http://www.atriahealth.co.

About AMS Cardiology

Founded in 1970, AMS Cardiology is a leading provider of high-quality cardiovascular disease care in the Greater Philadelphia Area, offering a comprehensive array of services, including general clinical cardiology, preventive cardiology and dyslipidemia management, cardio-oncology, cardio-obstetrics, echocardiography and nuclear cardiology, interventional cardiology, peripheral vascular disease, electrophysiology, valvular and structural heart disease. For more information, please visit http://www.amscardiology.com.

Share article on social media or email:

IntegriDATA Launches Expense Allocation Cloud (EAS Cloud SaaS)


IntegriDATA Launches Expense Allocation Cloud

IntegriDATA Launches Expense Allocation Cloud

EAS Cloud is faster to deploy, cost-effective, infinitely scalable, and always up to date

IntegriDATA, a leading private equity and hedge fund software provider, today announced EAS Expense Allocation Cloud, a fully hosted SaaS offering for its EAS Expense Allocation System. The new service, introduced in beta earlier this year, allows alternative investment advisors to automate the management and allocation of expenses without any in-house IT infrastructure. EAS Cloud is faster to deploy, cost-effective, infinitely scalable, and always up to date, making it easier than ever to improve expense accuracy and efficiency, and to ensure allocation compliance.

“Many of our clients are migrating their infrastructure to the cloud, and we are excited to help them on their journey,” said Mitch Schulman, CEO of IntegriDATA. “With EAS Cloud as a service, clients no longer need to think about installations and upgrades – open a browser, and it all just works.”

EAS Cloud Platform

EAS Cloud is powered by AWS and built with an AWS Premier Partner to AWS Well-Architected Framework best practices. Designed to SOC 2 security standards, EAS Cloud is hardened and secured using industry-leading security solutions. EAS Cloud is listed in the Cloud Security Alliance STAR registry.

Expense Allocation and EAS

Expense allocation is a complex private equity and hedge fund accounting process to proportionately distribute shared expenses across management companies and funds. The SEC made expense allocation a compliance priority after discovering alternative asset managers were unintentionally misallocating costs and causing investors to overpay expenses. Renewed as an investigative priority for 2022, SEC misallocation penalties often exceed $1 million.

IntegriDATA developed EAS to automate expense allocations and eliminate the risk of misallocation. With EAS, private equity and hedge fund managers can instantly perform complex allocations without the risk of costly mistakes. EAS also helps advisors manage general expenses and accounts payable with invoice and T&E collection, approval workflow, and automated journal entries.

Other EAS features:


  • Expense management and approval workflows
  • Accounts payable and receivable intercompany settlements
  • Allocation compliance and audit tools
  • Advanced allocation rule processing
  • APIs and accounting system integrations (e.g., QuickBooks, Intacct, Workday, Investran, Geneva)

About IntegriDATA IntegriDATA is a financial technology software company dedicated to helping the investment management industry improve operational efficiency and reduce risk. Founded in 2002 by financial industry experts, IntegriDATA specializes in expense allocation, payment automation, and collateral management solutions. IntegriDATA clients include hedge funds, private equity firms, fund administrators, institutional investors, and mutual funds. IntegriDATA software helps the investment management industry service over $1.6 trillion AUM.

For more information on IntegriDATA, please visit integri-data.com. Connect with IntegriDATA on LinkedIn, Facebook, and Twitter.

Share article on social media or email:



JPMA Cares to Host 2nd Annual Benefit for Babies December 1


JPMA Cares Benefit for Babies logo

JPMA Cares will host the 2nd annual Benefit for Babies on Thursday, Dec. 1, 2022, from 6:30-9:30 p.m. ET at SPIN New York 54.

“As JPMA Cares secures the right resources, we partner with like-minded charities to distribute these resources to people and places in high need,” said Executive Director of JPMA and JPMA Cares Lisa Trofe.

JPMA Cares will host the 2nd annual Benefit for Babies on Thursday, Dec. 1, 2022, from 6:30-9:30 p.m. ET at SPIN New York 54, 7 East 54th Street, New York, NY 10022. Those interested in advancing the health and safety of babies and young children are invited to attend, including manufacturers and retailers of baby and children’s products.

The JPMA Cares Benefit for Babies is all about coming together to have a good time while advancing the foundation’s mission, which is to contribute to the long-term success of babies and young children by reducing barriers to healthy development, ensuring fundamental needs are met, and promoting a safe and nurturing environment to learn and grow.

“JPMA Cares works to improve outcomes for all children and is intentional about meeting the needs of babies and young children,” said Executive Director of JPMA and JPMA Cares Lisa Trofe. “For some, the need is products or education, but for others, fundamental needs like housing, food and basic medical care are not being met. As JPMA Cares secures the right resources, we partner with like-minded charities to distribute these resources to people and places in high need. JPMA Cares has partnered with the Injury Free Coalition for Kids; Cradles to Crayons; Family Promise; and the United Nations Foundation to name a few.”

Benefit for Babies attendees will have the opportunity to enjoy networking, food, drinks, music and a silent auction at the event. SPIN New York 54 is a unique and vibrant ping pong venue, so those who are interested can also play ping pong while raising funds to support one of the world’s most vulnerable populations—babies and young children in need.

If you’re interested in attending Benefit for Babies, you may purchase tickets to the event at https://jpmacares.app.neoncrm.com/np/clients/jpmacares/eventRegistration.jsp?event=4. The cost is $280/person or $1,000 for a ping pong team of up to 4 people.

At Benefit for Babies, JPMA will also announce the following:


  • Winners of the prestigious Innovation Awards, which showcase the most ground-breaking new baby and children’s products in the marketplace today.
  • Core Values honorees, which are companies in the baby and children’s products industry that exemplify excellent Customer Care; Diversity, Equity & Inclusion; Integrity in Manufacturing Practices; Philanthropy; Safety; and Sustainability.

Additionally, JPMA Cares will honor Dr. Sadiqa Kendi with the 2022 Impact Award for making a positive impact on the long-term success of babies and young children. Dr. Kendi serves as the Division Chief of the Pediatric Emergency Medicine Division at Boston Medical Center and Boston University School of Medicine. She is an expert in pediatric injury prevention, with a focus on health equity.

JPMA Cares thanks the following organizations for their generous sponsorship of the 2022 Benefit for Babies: Amazon; the BreathableBaby Family of Brands; and ASTM International. Additionally, JPMA thanks Everyday Health Group Pregnancy & Parenting, which includes What to Expect and BabyCenter, for sponsoring the 2022 Innovation Awards.

If you have questions about JPMA Cares or Benefit for Babies, visit https://jpmacares.org or contact Meredith Birkhead at mbirkhead@jpmacares.org.

About JPMA Cares

JPMA Cares contributes to the long-term success of babies and young children by reducing barriers to healthy development, ensuring fundamental needs are met, and promoting a safe and nurturing environment for them to learn and grow. JPMA Cares is a 501(c)(3) charitable organization, founded by JPMA (the Juvenile Products Manufacturers Association) and supported by the broader baby and children’s products industry. Learn more at https://jpmacares.org.

About the Juvenile Products Manufacturers Association (JPMA)

The Juvenile Products Manufacturers Association (JPMA) is the voice of the industry on quality and safety for baby and children’s products in North America. We work to advance the interests of manufacturers, parents, children and the industry at large by advocating for safety through product certification programs and legislative and regulatory involvement. We support our broad and diverse membership through member-only programming and industry promotion, and we act as a comprehensive source for baby product information and education. Established in 1962, this year JPMA marks its 60th year of helping protect future generations by advancing the availability and safety of products used to care for babies and young children.

Share article on social media or email: